RGC
Regencell Bioscience Holdings Ltd
6.80$
+7.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 91.3% | 92.1% | 92.1% | 93.9% | 93.9% | 96.2% | 96.2% | 88.1% | 88.1% | 85.2% | 78.2% | 78.2% | |
| – | 12.4% | 12.4% | 45.8% | 45.8% | 35.1% | 35.1% | 39.6% | – | 42.0% | – | 78.2% | |
| – | 91.6% | 91.6% | 45.8% | 45.8% | 94.3% | 94.3% | 106.4% | – | 85.1% | – | 78.2% | |
| – | – | 0.4% | 0.5% | – | – | 1.8% | 2.0% | – | – | – | – | |
| – | – | -0.4% | -0.5% | – | – | – | -2.0% | – | – | – | – | |
| 5.6% | 5.0% | 5.0% | 3.0% | 3.0% | 2.6% | 2.6% | 10.2% | 10.2% | 15.6% | 59.5% | 59.5% | |
| – | 4.8% | 4.8% | 5.8% | – | 2.3% | 2.3% | 2.6% | – | 11.5% | – | 55.3% | |
| – | 3,472.5% | 3.5% | 4.2% | – | 0.7% | 0.7% | 1.6% | – | 5.4% | – | 8.6% | |
| 94.3% | 95.3% | 95.3% | 97.0% | 97.0% | 97.4% | 97.4% | 89.8% | 89.8% | 84.4% | 40.5% | 40.5% | |
| – | -137.2% | -137.2% | -165.3% | – | -256.2% | -256.2% | -289.0% | – | -437.9% | – | -1,012.8% | |
| 3,180.4% | 103,098.0% | 3,917.8% | 4,720.3% | 4,720.3% | 5,859.9% | 5,859.9% | 6,611.5% | 6,611.4% | 8,591.5% | 16,409.7% | 16,409.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.